Eva Boratto

Executive Vice President and Chief Financial Officer Cencora

Last Reviewed: October 1, 2026

Executive Summary

Eva Boratto became Cencora’s Chief Financial Officer on 29 June 2026, succeeding the retiring James Cleary. She leads the finance organisation, including financial strategy, productivity priorities and capital allocation. She brings more than three decades of finance leadership in healthcare and retail: 20 years at Merck, 12 years at CVS Health, where she rose from chief accounting officer to chief financial officer, and CFO roles at the life sciences company Opentrons and at Bath & Body Works. She chairs the audit committee of Mars, Inc. Cencora ranked No. 10 on the 2026 Fortune 500.

Career Highlights

• Executive Vice President and Chief Financial Officer of Cencora since June 2026.
• Chief Financial Officer of Bath & Body Works, August 2023 to 2026.
• Executive Vice President and Chief Financial Officer of CVS Health, 2018 to 2021.
• 20 years at Merck & Co. in finance and investor relations.
• Director of Mars, Inc., chairing its audit committee; former UPS director.

Professional Journey

Boratto earned a Bachelor of Science in accounting and economics at Rutgers University and an MBA at Drexel University. She spent 20 years at Merck & Co. in finance and investor relations leadership roles.

At CVS Health she was Senior Vice President and Chief Accounting Officer from 2013, Executive Vice President, Controller and Chief Accounting Officer from 2017, and Executive Vice President and Chief Financial Officer from 2018 to 2021. She was then CFO of the privately held life sciences company Opentrons Labwork from February 2022 and of Bath & Body Works from August 2023.

She joined Cencora as Executive Vice President and Chief Financial Officer on 29 June 2026. She serves on the board of Mars, Inc., where she chairs the audit committee, and previously chaired the audit committee of UPS.

Education

Drexel University

MBA

Rutgers University

Bachelor of Science, Accounting and Economics